Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Other Non-Current Liabilities (2021 - 2025)

Medicinova (MNOV) has disclosed Other Non-Current Liabilities for 5 consecutive years, with $17129.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities changed N/A to $17129.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17129.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $17129.0 for FY2025, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $17129.0 at Medicinova, down from $74399.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $737716.0 in Q3 2021, with the low at $2211.0 in Q1 2021.
  • Average Other Non-Current Liabilities over 5 years is $359103.6, with a median of $380922.5 recorded in 2023.
  • The sharpest move saw Other Non-Current Liabilities soared 28523.65% in 2022, then tumbled 70.84% in 2025.
  • Over 5 years, Other Non-Current Liabilities stood at $694674.0 in 2021, then dropped by 19.99% to $555840.0 in 2022, then decreased by 26.12% to $410660.0 in 2023, then plummeted by 37.87% to $255150.0 in 2024, then tumbled by 93.29% to $17129.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $17129.0, $74399.0, and $117038.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.